• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯取代对含钒配合物降低糖尿病高血糖的作用及其通透性和细胞毒性。

Effect of the chloro-substitution on lowering diabetic hyperglycemia of vanadium complexes with their permeability and cytotoxicity.

机构信息

Department of Chemistry, Yunnan University, Kunming 650091, China.

出版信息

Eur J Med Chem. 2010 Dec;45(12):6077-84. doi: 10.1016/j.ejmech.2010.10.013. Epub 2010 Oct 16.

DOI:10.1016/j.ejmech.2010.10.013
PMID:21036421
Abstract

The effect of the chloro-substitution of dinuclear vanadium (V) complexes on lowering diabetic hyperglycemia was evaluated. The in vivo tests for hypoglycemic activity show that complex 2 at the dose of 10.0 and 20.0 mg V kg(-1), could significantly decrease the blood glucose level. Importantly, our results the chloro substituent increased the insulin-enhancing properties of the complex 2. The two vanadium compounds had permeability above 10(-5) cm/s. It suggested that two complexes permeate via a passive diffusion mechanism. It was also suggested that two complexes has better good lipophilic properties. The cytotoxicity of two complexes on Caco-2 cells suggested the chlorine atom at C4 of complex 2 increased cytotoxicity for vanadium complexes.

摘要

我们评估了双核钒(V)配合物的氯取代基对降低糖尿病高血糖的影响。体内试验表明,配合物 2 在 10.0 和 20.0 mg V kg(-1)剂量下,能显著降低血糖水平。重要的是,我们的结果表明,氯取代基增加了配合物 2 的胰岛素增强特性。这两种钒化合物的透过率均高于 10(-5) cm/s。这表明两种配合物通过被动扩散机制渗透。这也表明两种配合物具有更好的亲脂性。两种配合物对 Caco-2 细胞的细胞毒性表明,配合物 2 中 C4 上的氯原子增加了钒配合物的细胞毒性。

相似文献

1
Effect of the chloro-substitution on lowering diabetic hyperglycemia of vanadium complexes with their permeability and cytotoxicity.氯取代对含钒配合物降低糖尿病高血糖的作用及其通透性和细胞毒性。
Eur J Med Chem. 2010 Dec;45(12):6077-84. doi: 10.1016/j.ejmech.2010.10.013. Epub 2010 Oct 16.
2
Insulin-enhancing activity of a dinuclear vanadium complex: 5-chloro-salicylaldhyde ethylenediamine oxovanadium(V) and its permeability and cytotoxicity.双核钒配合物增强胰岛素活性的研究:5-氯水杨醛乙二胺氧钒(V)及其通透性和细胞毒性。
J Inorg Biochem. 2010 Aug;104(8):851-7. doi: 10.1016/j.jinorgbio.2010.03.018. Epub 2010 Apr 8.
3
Aqueous chemistry of the vanadium(III) (V(III)) and the V(III)-dipicolinate systems and a comparison of the effect of three oxidation states of vanadium compounds on diabetic hyperglycemia in rats.钒(III)(V(III))和V(III)-二吡啶甲酸盐体系的水相化学以及钒化合物三种氧化态对大鼠糖尿病高血糖影响的比较。
Inorg Chem. 2005 Jul 25;44(15):5416-27. doi: 10.1021/ic048331q.
4
In vivo insulin-mimetic activity of [N,N'-1,3-propyl-bis(salicyladimine)]oxovanadium(IV).[1,3-丙基双(水杨醛亚胺)]氧钒(IV)的体内胰岛素模拟活性
Eur J Med Chem. 2007 Jun;42(6):817-22. doi: 10.1016/j.ejmech.2006.12.021. Epub 2007 Jan 12.
5
Anti-diabetic effects of vanadium(III, IV, V)-chlorodipicolinate complexes in streptozotocin-induced diabetic rats.氯代二吡啶酸合钒(III、IV、V)复合物对链脲佐菌素诱导的糖尿病大鼠的抗糖尿病作用。
Biometals. 2009 Dec;22(6):895-905. doi: 10.1007/s10534-009-9241-4.
6
Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.含双齿麦芽醇型配体的氧钒配合物的制备与表征;抗糖尿病治疗潜力的体内比较
J Biol Inorg Chem. 2003 Jan;8(1-2):66-74. doi: 10.1007/s00775-002-0388-5. Epub 2002 Sep 12.
7
Chloro-substituted dipicolinate vanadium complexes: synthesis, solution, solid-state, and insulin-enhancing properties.氯代二吡啶甲酸钒配合物:合成、溶液性质、固态性质及胰岛素增强特性
J Inorg Biochem. 2009 Apr;103(4):575-84. doi: 10.1016/j.jinorgbio.2008.12.015. Epub 2008 Dec 31.
8
Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats.双(α-呋喃甲酸根)氧钒(IV)对高脂喂养/链脲佐菌素诱导糖尿病大鼠葡萄糖代谢的影响
Eur J Pharmacol. 2007 Oct 31;572(2-3):213-9. doi: 10.1016/j.ejphar.2007.05.071. Epub 2007 Jun 19.
9
A new insulin-enhancing agent: [N,N'-bis(4-hydroxysalicylidene)-o-phenylene-diamine]oxovanadium(IV) and its permeability and cytotoxicity.一种新的胰岛素增强剂:[N,N'-双(4-羟基水杨醛基)-邻苯二胺]氧钒(IV)及其通透性和细胞毒性。
Eur J Med Chem. 2010 Jun;45(6):2327-35. doi: 10.1016/j.ejmech.2010.02.010. Epub 2010 Feb 10.
10
Synthesis, characterization and anti-diabetic therapeutic potential of a new benzyl acid-derivatized kojic acid vanadyl complex.一种新的苯甲酰基衍生物熊果酰氧钒配合物的合成、表征及抗糖尿病治疗潜力。
Biometals. 2012 Dec;25(6):1261-8. doi: 10.1007/s10534-012-9587-x. Epub 2012 Sep 27.

引用本文的文献

1
Stabilization of two conformers intra- or inter-molecular hydrogen bonds in a dinuclear vanadium(v) complex with a pendant Schiff base: theoretical insight.具有侧链席夫碱的双核钒(V)配合物中两个构象异构体分子内或分子间氢键的稳定性:理论见解
RSC Adv. 2019 Nov 6;9(60):35165-35175. doi: 10.1039/c9ra07006k. eCollection 2019 Oct 28.
2
Vanadium(IV) Complexes with Methyl-Substituted 8-Hydroxyquinolines: Catalytic Potential in the Oxidation of Hydrocarbons and Alcohols with Peroxides and Biological Activity.钒(IV)配合物与甲基取代的 8-羟基喹啉:在过氧化物氧化烃和醇中的催化潜力和生物活性。
Molecules. 2021 Oct 21;26(21):6364. doi: 10.3390/molecules26216364.
3
Antidiabetic vanadium compound and membrane interfaces: interface-facilitated metal complex hydrolysis.
抗糖尿病钒化合物与膜界面:界面促进的金属配合物水解。
J Biol Inorg Chem. 2011 Aug;16(6):961-72. doi: 10.1007/s00775-011-0796-5. Epub 2011 Jun 11.